Pharmaceuticals And Medical Devices Agency

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.481 documents for Pharmaceuticals And Medical Devices Agency

- Critical Path Institute's Predictive Safety Testing Consortium (PSTC) Announces First-Ever Biomarker Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
PSTC's New Kidney Biomarkers Accepted by PMDA as Useful in Assessing the Safety of New Drugs TUCSON, Ariz. -- For the first time, new biomarker test...
- Business Wire
- June 24, 2010
- Life Sciences Newsbriefs: Week of 6 December 2010
CONTENTS:. Medical Devices Drugs & Biologics Food & Dietary Medic... for clearing medical devices that the agency seeks to start implementing in 2011, along with a ... in New York has ordered Angiotech Pharmaceuticals to comply with the terms of a 2008 agreement regar...
- Mondaq Business Briefing
- United States Law Articles in English
- Genetic Hair Loss Test Now Introduced In Australia Through HairDX Distribution Agreement With Advanced Hair Studio.
... kit is listed with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and the United S...
- Business Wire
- September 22, 2009

- Lilly Ceo Calls for Biopharmaceutical Industry Changes and Policies That Encourage Medical Innovation ; Lechleiter Addresses U.S./Japan Business Council in Tokyo
TOKYO, March 9, 2011 /PRNewswire/ -- To address growing unmet medical needs and strengthen the global economy, new approaches to biopharmaceutical research and policies that support innovation are critical, according to John Lechleiter, Ph.D., chairman, president and CEO of Eli Lilly and Company (NYSE: LLY). In remarks to the U.S./Japan Business Council Wednesday in Tokyo, Lechleiter outlined two imperatives to secure the future of the research-based pharmaceutical industry and help stimulate the global economy: changing the way companies conduct research - or "reinventing invention" - and implementing public policies that promote an environment in which medical innovation can thrive.

...He encouraged the Pharmaceuticals and Medical Devices Agency (PMDA) to continue to a...
- U.S. Newswire
- March 09, 2011
- Sucampo Pharmaceuticals Reports Third Quarter 2010 Financial Results.
... to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza for ...
- Business Wire
- November 03, 2010
- Sucampo Pharmaceuticals, Inc. Reports Third Quarter 2011 and Year to Date Financial Results.
... to patients with significant unmet medical needs on a global basis as well as vigorously prot... the Japanese Pharmaceuticals and Medical Devices Agency (PMDA), is proceeding as expected. We have ...
- Business Wire
- November 03, 2011
- DIA 2011 Features New Experiences, Expanded Content, Same Commitment to Quality.
..., and life cycle management of pharmaceuticals, biotechnology, medical devices, and related healt...* Professional Development. * New! Global Agency. * New! SIAC Showcase. DIA 2011 is moving in a new...
- Business Wire
- March 02, 2011
- Sucampo Pharmaceuticals Submits Marketing Application to Japanese Regulatory Authorities for Amitiza (lubiprostone).
... to the Japanese Pharmaceuticals and Medical Devices Agency for approval to market Amitiza([R])...
- Business Wire
- October 07, 2010
- Medtronic Resolute[R] Drug-Eluting Stent Shows Superiority to Taxus[R] DES in Study of Patients with Coronary Artery Disease.
- Business Wire
- July 25, 2011
- Novella Clinical Names Director of Marketing.
... programs in life sciences, pharmaceuticals, medical devices and diagnostics in both agency an...
- Business Wire
- March 29, 2011